Combined mutational analysis of RAS, BRAF, PIK3CA, and TP53 genes in Taiwanese patients with oral squamous cell carcinoma

Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Jul;118(1):110-116.e1. doi: 10.1016/j.oooo.2014.03.016. Epub 2014 Apr 5.

Abstract

Objective: Many genetic factors have been implicated in the development of oral squamous cell carcinoma (OSCC). Although mutations associated with OSCC have been well documented, the rate of these mutations is known to vary by location. The goal of this study was to determine the frequency of RAS, BRAF, PIK3CA, and TP53 mutations in OSCC within the Taiwanese population.

Study design: A total of 79 OSCC tissue specimens were screened for the presence of RAS, BRAF, PIK3CA, and TP53 mutations.

Results: Missense mutations in HRAS were found in 10 of 79 cases (12.66%), and were significantly associated with tumor grade. PIK3CA mutations were observed in 11 of 79 cases (13.92%), including a rare mutation, Q546 P, that had not previously been reported in OSCC. TP53 mutations were observed in 26 of 79 patients (32.91%) and were significantly correlated with poor survival.

Conclusions: The results suggest that HRAS, PIK3CA, and TP53 may play a role in OSCC tumorigenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / genetics
  • Carcinoma, Squamous Cell / genetics*
  • Carcinoma, Squamous Cell / pathology
  • Class I Phosphatidylinositol 3-Kinases
  • DNA Mutational Analysis
  • Female
  • Genes, p53 / genetics
  • Genes, ras / genetics
  • Humans
  • Male
  • Middle Aged
  • Mouth Neoplasms / genetics*
  • Mouth Neoplasms / pathology
  • Mutation, Missense
  • Neoplasm Grading
  • Phosphatidylinositol 3-Kinases / genetics
  • Polymerase Chain Reaction
  • Prognosis
  • Proto-Oncogene Proteins B-raf / genetics
  • Survival Rate
  • Taiwan

Substances

  • Biomarkers, Tumor
  • Phosphatidylinositol 3-Kinases
  • Class I Phosphatidylinositol 3-Kinases
  • PIK3CA protein, human
  • Proto-Oncogene Proteins B-raf